Bristlecone Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-17,124
| Closed | -$1.08M | – | 198 |
|
|
2020
Q3 | $1.08M | Sell |
17,124
-7,002
| -29% | -$442K | 0.2% | 101 |
|
|
2020
Q2 | $1.86M | Buy |
24,126
+15,741
| +188% | +$1.21M | 0.38% | 70 |
|
|
2020
Q1 | $627K | Buy |
8,385
+65
| +0.8% | +$4.86K | 0.15% | 111 |
|
|
2019
Q4 | $541K | Buy |
8,320
+305
| +4% | +$19.8K | 0.11% | 131 |
|
|
2019
Q3 | $508K | Sell |
8,015
-3,579
| -31% | -$227K | 0.12% | 111 |
|
|
2019
Q2 | $783K | Sell |
11,594
-13,752
| -54% | -$929K | 0.19% | 97 |
|
|
2019
Q1 | $1.65M | Sell |
25,346
-665
| -3% | -$43.2K | 0.46% | 64 |
|
|
2018
Q4 | $1.63M | Sell |
26,011
-25
| -0.1% | -$1.56K | 0.49% | 68 |
|
|
2018
Q3 | $2.01M | Buy |
26,036
+11,741
| +82% | +$906K | 0.51% | 58 |
|
|
2018
Q2 | $1.01M | Sell |
14,295
-4,418
| -24% | -$313K | 0.34% | 73 |
|
|
2018
Q1 | $1.41M | Sell |
18,713
-6,732
| -26% | -$508K | 0.47% | 56 |
|
|
2017
Q4 | $1.82M | Sell |
25,445
-1,085
| -4% | -$77.7K | 0.58% | 50 |
|
|
2017
Q3 | $2.15M | Sell |
26,530
-25
| -0.1% | -$2.03K | 0.7% | 42 |
|
|
2017
Q2 | $1.88M | Sell |
26,555
-345
| -1% | -$24.4K | 0.64% | 51 |
|
|
2017
Q1 | $1.83M | Sell |
26,900
-760
| -3% | -$51.6K | 0.64% | 49 |
|
|
2016
Q4 | $1.98M | Buy |
27,660
+2,570
| +10% | +$184K | 0.71% | 46 |
|
|
2016
Q3 | $1.99M | Buy |
+25,090
| New | +$1.99M | 0.72% | 45 |
|
|
2016
Q2 | – | Sell |
-24,787
| Closed | -$2.28M | – | 144 |
|
|
2016
Q1 | $2.28M | Buy |
24,787
+1,300
| +6% | +$119K | 0.9% | 33 |
|
|
2015
Q4 | $2.38M | Buy |
+23,487
| New | +$2.38M | 1% | 23 |
|